If you have been reading about DMSO stock and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-03-04. Numbers and descriptions here follow the published literature rather than marketing material.
SR9009 is a synthetic small molecule developed as an agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These receptors help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, SR9009 alters transcription of genes involved in lipid metabolism, inflammation, and mitochondrial function. It is not an approved medicine, and its pharmacological profile in humans remains largely uncharacterized. The compound is frequently discussed in the context of circadian biology and metabolic research rather than clinical use.
Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.
The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Small molecule; not a steroid or peptide. |
| Primary targets | NR1D1 and NR1D2 | Also known as REV-ERBα and REV-ERBβ. |
| Studied routes | Intraperitoneal in rodents | Oral bioavailability in humans is not established. |
| Human approval | No approved therapeutic indication | No recognized clinical use. |
| Key uncertainty | Human physiological effects | Preclinical findings may not translate. |
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
Laboratory identification of SR9009 typically relies on chromatographic separation coupled to mass spectrometry, often with ultraviolet detection as a secondary check. Nuclear magnetic resonance spectroscopy can confirm molecular structure when a reference standard is available. Because many suppliers sell the compound as a research chemical, independent identity testing is important for experimental reproducibility. A single retention time is not sufficient proof of identity, especially when related compounds may be present. Purity assessments usually report a percentage based on area normalization.
SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.
For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.
COVID-19 in the UK: ONS data for the week up to 10 January indicates that COVID-19 infections have continued to fall in England and Wales, with one in 40 people (an estimated 2.6% of the population) testing positive for the virus. 22 January – Labour's chairwoman, Anneliese Dodds writes to Daniel Greenberg, the Parliamentary Commissioner for Standards, requesting "an urgent investigation" into claims that Richard Sharp, the chairman of the BBC, helped former prime minister Boris Johnson secure a loan guarantee weeks before Johnson recommended him for the BBC chairmanship. 23 January Prime Minister Rishi Sunak asks his Independent Adviser on Ministers' Interests to investigate allegations that, during his time as Chancellor of the Exchequer, Chairman of the Conservative Party Nadhim Zahawi paid a penalty to HM Revenue and Customs in relation to previously unpaid tax. William Shawcross, the Commissioner for Public Appointments, begins a review into the process of hiring Chairman of the BBC Richard Sharp following allegations he helped then-PM Boris Johnson secure a loan guarantee shortly before his appointment. Johnson dismisses the claims, saying Sharp had no knowledge of his finances. Sharp says that although he contacted Cabinet Secretary Simon Case in December 2020 about the offer of a loan to Johnson, he was not involved in discussions. National Grid's Demand Flexibility Service begins in an attempt to avoid a power blackout.
Enantiomers of propranolol, metoprolol, chlorpheniramine, verapamil, hexobarbitaI, methadone and much more drugs have been separated using immobilized β-cyclodextrin. Initially natural CDs have been used as the chiral selector. Later, modified cyclodextrin structures have been prepared by derivatizing the secondary hydroxyl groups present on the CD molecule. Incorporation of these additional functional groups may improve the chiral recognition capability by possibly modifying the chiral pocket and creating extra auxiliary interaction site. This approach enabled to expand the range of target chiral analytes that could be separated. A number of chiral pharmaceuticals has been resolved using derivatized CDs including ibuprofen, suprofen, flurbiprofen from NSAID category and b-blockers like metoprolol and atenolol. A brief list of cyclodextrin-based chiral stationary stationary phases available in the market is furnished in the table below.
On July 16, 1945, the first atomic bomb test took place near the town of Alamogordo (New Mexico, USA). As a result of the atmospheric nuclear weapons tests carried out by the United States, the Soviet Union, France, Great Britain, and China, the Earth's atmosphere became increasingly contaminated with fission products from these tests from the 1950s onwards. The radioactive fallout landed on the earth's surface and ended up in plants and, via animal feed, in food of animal origin. Ultimately, they entered the human body and could be detected in bones and teeth as strontium-90, among other things. The radioactivity in the field was measured with a gamma scope, as shown at the air raid equipment exhibition in Bad Godesberg in 1954. Around 180 tests were carried out in 1962 alone. The extent of the radioactive contamination of the food sparked worldwide protests in the early 1960s.
Sources: en.wikipedia.org
== History == In the early 2000s, researchers began exploring the use of PSMA as a target for imaging and therapy. The first PSMA-targeted radiotracer was developed using a different radioactive element, technetium-99m. This radiotracer, called 99mTc-MIP-1404, showed promise in preclinical studies but did not perform well in clinical trials. In 2011, researchers started investigating the use of gallium-68, a different radioactive element, as a more suitable alternative for PSMA-targeted radiotracers. In 2013, the first Ga-PSMA radiotracer was developed by researchers at DKFZ in Germany, and it showed promising results in early clinical studies. Since then, Ga-PSMA has been extensively studied in clinical trials, and it has been found to be a highly effective imaging agent for detecting prostate cancer lesions. It is now widely used in clinical practice, particularly for patients with recurrent prostate cancer and those with high-risk disease. Initially gallium (68Ga) chloride solution injections used for radiolabelling, in 2019 European Pharmacopoeia mentions gallium (68Ga) DOTATOC injection for radiolabelling and PET imaging. Ga 68 PSMA-11 was co-developed by researchers at University of California, Los Angeles and University of California, San Francisco, who conducted a phase III clinical trial. In December 2020, the drug was first approved by the US Food and Drug Administration (FDA) for PET imaging.
Preclinical research suggests that several derivatives of aromatic amino acids with antiglutamatergic properties including AMPA receptor antagonism and inhibition of glutamate release such as 3,5-dibromo-D-tyrosine and 3,5-dibromo-L-phenylalnine exhibit strong anticonvulsant effect in animal models suggesting use of these compounds as a novel class of antiepileptic drugs.
Schleiden was a microscopist and an early plant anatomist who co-founded the cell theory with Theodor Schwann and Rudolf Virchow and was among the first to grasp the significance of the cell nucleus that had been described by Robert Brown in 1831. In 1855, Adolf Fick formulated Fick's laws that enabled the calculation of the rates of molecular diffusion in biological systems.
=== Canada === Vesta Creek (Alberta), a stream in northern Alberta Vesta Creek (Ontario), a stream in Bruce County, Ontario Vesta, a dispersed rural community in the municipality of Brockton, Bruce County, Ontario
Sources: en.wikipedia.org
Hexamers are characteristic of arthropod hemocyanins. A hemocyanin of the tarantula Eurypelma californicum is made up of 4 hexamers or 24 peptide chains. A hemocyanin from the house centipede Scutigera coleoptrata is made up of 6 hexamers or 36 chains. Horseshoe crabs have an 8-hexamer (i. e. 48-chain) hemocyanin. Simple hexamers are found in the spiny lobster Panulirus interruptus and the isopod Bathynomus giganteus. Peptide chains in crustaceans are about 660 amino acid residues long, and in chelicerates they are about 625. In the large complexes there is a variety of variant chains, all about the same length; pure components do not usually self-assemble.
As the Left Opposition to Stalin within the Soviet party and government, Leon Trotsky and Trotskyists argued that Marxist–Leninist ideology contradicted Marxism and Leninism in theory, therefore Stalin's ideology was not useful for the implementation of socialism in Russia. Moreover, Trotskyists within the party identified their anti-Stalinist communist ideology as Bolshevik–Leninism and supported the permanent revolution to differentiate themselves from Stalin's justification and implementation of socialism in one country. After the Sino-Soviet split of the 1960s, the Chinese Communist Party and the Communist Party of the Soviet Union claimed to be the sole heir and successor to Stalin concerning the correct interpretation of Marxism–Leninism and ideological leader of world communism. In that vein, Mao Zedong Thought, Mao Zedong's updating and adaptation of Marxism–Leninism to Chinese conditions in which revolutionary praxis is primary and ideological orthodoxy is secondary, represents urban Marxism–Leninism adapted to pre-industrial China. The claim that Mao had adapted Marxism–Leninism to Chinese conditions evolved into the idea that he had updated it in a fundamental way applying to the world as a whole. Consequently, Mao Zedong Thought became the official state ideology of the People's Republic of China as well as the ideological basis of communist parties around the world which sympathised with China.
== Health aspects == Fruits that are rich in polyphenol oxidase activity may affect the polyphenol content of other fruits consumed in the same meal. In particular mixed fruit juices and smoothies are at risk, as different fruits (and their cellular content) are mixed long time before digestion enzymes can inactivate the polyphenol oxidase. Thus, these beverages contain considerably less bioactive polyphenoles compared to fruit juices made entirely of low-PPO fruits or whole fruits.
Sources: en.wikipedia.org
It is a synthetic compound that acts as an agonist at REV-ERBα and REV-ERBβ. It is used mainly as a research chemical to study circadian and metabolic pathways. It is not approved for human therapeutic use.
REV-ERB receptors generally repress transcription when bound by natural heme. SR9009 is described as an agonist that enhances this repressive activity. The result is altered expression of clock and metabolic genes.
Published controlled human trials are lacking. Some sources cite limited or unofficial reports, but these do not establish safety or efficacy. Claims about human performance effects remain unverified.
SR9009 is a synthetic REV-ERB agonist used in laboratory research. It is not an approved drug, and its effects in humans are not well characterized. It is often sold as a research chemical under the name Stenabolic.